ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|
|

Trending News

Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial

Can Glycine + Amino Acids Be the Secret to Deep, Rejuvenating Sleep?

Exploring the association between Morgellons disease and Lyme disease: identification of Borrelia bu...

Lyme Disease Activists Take Fight to Washington D.C.

New Envita Study Shows Chronic Lyme Disease "Fools" Immune System, Resistant to Antibiotics

Safely Burn Away Body Fat

Omega-3 fatty acids boost B vitamin brain benefit

Substantial health threat: Never-before-seen tick-borne disease

Lyme Advocates Call on IDSA to Focus on Patient Care Instead of Attacking Those in Distress

Zinc deficiency linked to chronic inflammation

 
Print Page
Email Article

Interstitial Cystitis Prognosis Generally Worse in ME/CFS Patients

  [ 7 votes ]   [ Discuss This Article ]
www.ProHealth.com • August 14, 2012


Article:
Prognostic factors for recent-onset interstitial cystitis/painful bladder syndrome
- Source: British Journal of Urology International (BJUI), Aug 9, 2012

By John W Warren, Daniel J Clauw, Patricia Langenberg

[Note: IC/PBS is frequently diagnosed in ME/CFS patients (and fibromyalgia patients as well); though within the large IC/PBS patient population those with ME/CFS are considered a relatively small subset.]

Abstract:
Study Type: Prognosis (case series)

Interstitial cystitis/painful bladder syndrome (IC/PBS) comprises pain perceived to be from the bladder, urinary urgency and frequency, and nocturia.

As diagnosed at present, it is primarily identified in adult women. It is a chronic disease yet its natural history has not been well studied.

In a prospective study of 304 incident female IC/PBS cases followed for a median of 33 months after onset, women with baseline chronic fatigue syndrome had a worse prognosis for IC/PBS.

Mild IC/PBS at baseline was the only variable that was directly associated with a good prognosis.

Objective: To identify baseline variables that predict the prognosis of interstitial cystitis/painful bladder syndrome (IC/PBS) in women seeking medical care for recent onset of this syndrome.

Subjects and Methods:

In a prospective study of women with incident IC/PBS (12 months or less of symptoms), we contacted patients at intervals and asked standardized questions about IC/PBS symptoms in the previous week.

Logistic regression analyses assessed baseline variables as predictors of mild vs more severe IC/PBS at the last follow-up.

Results:

Median length of follow-up was 33 months after onset of IC/PBS; 304 (97%) patients had at least one follow-up assessment.

• Mild IC/PBS at baseline was the only variable that was directly associated with a mild IC/PBS endpoint.

• Conversely, a history of chronic fatigue syndrome (CFS) was inversely associated with a mild endpoint of IC/PBS (i.e. individuals with CFS had a worse prognosis for their IC/PBS symptoms).

Conclusions:

• At a median of nearly 3 years after onset, baseline mild IC/PBS was directly associated with a milder disease severity.

• Baseline co-morbid CFS was associated with more severe disease.

Source: British Journal of Urology International (BJUI), Aug 9, 2012. Warren JW, Clauw DJ, Langenberg P. Department of Medicine Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD; Departments of Anesthesiology and Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA.



Please Discuss This Article:   Post a Comment 



[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Save on Vitamins and Supplements

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Vitamin D3 Extreme™ by ProHealth Vitamin D3 Extreme™ by ProHealth
50,000 IU Vitamin D3 - Prescription Strength
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Optimized Curcumin Longvida® by ProHealth Optimized Curcumin Longvida® by ProHealth
Supports Cognition, Memory & Overall Health

Natural Remedies

Coenzyme Q10 - The Energy Maker Coenzyme Q10 - The Energy Maker
Strontium - The Missing Mineral for Strong Bones Strontium - The Missing Mineral for Strong Bones
Fighting Fatigue with Ground-breaking French Oak Wood Extract Fighting Fatigue with Ground-breaking French Oak Wood Extract
Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery
Guarding Against the Dangers of Vitamin D Deficiency Guarding Against the Dangers of Vitamin D Deficiency

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia Diagnosis
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS Diagnosis
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE  |  PRIVACY
CONTACT US
LIBRARY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing